SuperworthOrchestra BioMed market cap OBIO
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $336M
- Highest close in our data
- $607.8M
- May 2023
Orchestra BioMed is worth $336M at the close on Oct 23, 2026, at $5.59 a share.
That is up 57% over the last year and up 67% over five years.
Its highest close in our data was $607.8M in May 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $336M | $197.1M | $367.8M | +38% |
| 2025 | $243.9M | $93.5M | $300.4M | +46% |
| 2024 | $167.3M | $157.1M | $311.7M | −49% |
| 2023 | $326.3M | $99.7M | $607.8M | +192% |
| 2022 | $111.9M | $110.2M | $204.9M | −46% |
| 2021 | $206.1M | $200.2M | $293.9M | −21% |
| 2020 | $262M | $222.9M | $262M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orchestra BioMed's size, closest first, today.
| Company | Market cap |
|---|---|
| OBIOOrchestra BioMed | $336M |
| EMBCEmbecta | $380.2M |
| INFUInfuSystem | $277.6M |
| UTMDUtah Medical Products | $236.3M |
| TCMDTactile Systems Technology | $535.5M |
| PDEXPro DEX | $199.3M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $457.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Orchestra BioMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.